Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05695911 · ClinicalTrials.gov registry record · NA

Transfemoral Osseointegrated Prosthesis Limb-Load Symmetry Training

A NA study of Amputation and Transfemoral Amputation, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05695911: Active NA study of Amputation and Transfemoral Amputation, sponsored by University of Colorado, Denver.

NCT05695911 is a NA study of Amputation and Transfemoral Amputation that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 25 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05695911, a NA study of Amputation and Transfemoral Amputation, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled trial (n=25 enrolled, n=15 expected to complete) will 1) determine the feasibility of a 40-week limb-load biofeedback training intervention, 2) determine if there is an intervention signal of efficacy, and 3) identify functional movement priorities for people with transfemoral osseointegrated (OI) prostheses. A limb-load biofeedback training group (EXP (n=10)) will be compared to a standard of care attention-control group without limb-load biofeedback training (CTL (n=5)). Outcomes will be assessed at standard of care pre-habilitation end (Week 5), standard of care rehabilitation end (Week 24), and one year after OI Stage 2 surgery (Week 64).

Primary Outcome

Intervention feasibility is measured by retention rate, the percentage of people that complete the study. A score can range between 0 and 100 percent with 100 percent meaning all randomized participants completed the study.

Interventions

  • OTHER Attention Control
  • BEHAVIORAL Limb Load Biofeedback Training Intervention

Study Locations (1)

Colorado

  • CU Physical Therapy - Aurora

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-01-30
Est. Completion 2027-01-31
Phase NA
University of Colorado, Denver

1,283 total trials

What the registry record for NCT05695911 still lists

NCT05695911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (81% lower).

The record links to 3 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.

NCT05695911 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05695911 about?

NCT05695911 is a clinical study titled "Transfemoral Osseointegrated Prosthesis Limb-Load Symmetry Training". This randomized controlled trial (n=25 enrolled, n=15 expected to complete) will 1) determine the feasibility of a 40-week limb-load biofeedback training intervention, 2) determine if there is an intervention signal of efficacy, and 3) identify functional movement priorities for people with transfem...

What is the current status of trial NCT05695911?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-01-30. Estimated completion is 2027-01-31.

What conditions does trial NCT05695911 study?

This clinical trial studies the following conditions: Amputation, Transfemoral Amputation, Osseointegration.

What interventions are being tested in trial NCT05695911?

The interventions under investigation include: Attention Control (OTHER), Limb Load Biofeedback Training Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05695911?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05695911 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05695911's enrollment target sits among peer trials

25 32nd of 65 higher than 34 of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05695911, the US trial registry maintained by the National Library of Medicine. NCT05695911 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.